Company news: Elixinol Global; Bod Australia; MGC Pharma; Cronos Australia; Epsilon Healthcare by Martin Lane April 23, 2021April 29, 2021 Elixinol Global Elixinol Global has reported revenue of A$2.3 million for the March quarter, down 26% […]
Bod to trial medicinal cannabis product as treatment for Long Covid by Martin Lane March 19, 2021March 25, 2021
Industry reacts to TGA down-scheduling decision with cautious optimism by Martin Lane December 17, 2020December 17, 2020
ASX-listed cannabis companies look to finance their next stages of growth by Martin Lane December 14, 2020December 14, 2020
Bod Australia sees 106% increase in monthly MediCabilis prescriptions by Emma Castle November 18, 2020November 18, 2020
Bod Australia furthers European expansion, with plans for US market underway by Martin Lane October 20, 2020October 20, 2020